Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead challenges GSK with strong HIV drug data
Yahoo/Reuters
Tue, 02/14/17 - 09:28 am
Tags:
Gilead Sciences, GSK, HIV, bictegravir, Dolutegravir
Is Gilead Sciences Getting Ready for a Massive Acquisition?
Motley Fool
Mon, 02/13/17 - 10:12 am
Tags:
Gilead Sciences, M&A
Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy
Medical Marketing and Media
Thu, 02/9/17 - 11:16 am
Tags:
Gilead Sciences, social media, Truvada, HIV
GlaxoSmithKline and Gilead to face off at HIV meeting next week
Yahoo/Reuters
Thu, 02/9/17 - 09:44 am
Tags:
GSK, Gilead Sciences, HIV, bictegravir, Dolutegravir
Gilead cured hepatitis C. That’s become its biggest problem
Marketwatch
Wed, 02/8/17 - 09:27 pm
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Gilead’s Biggest Blockbusters Are Fading Fast, Biotech Warns
Bloomberg
Wed, 02/8/17 - 09:21 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Gilead 2017 hepatitis C sales forecast disappoints, shares drop
Yahoo/Reuters
Tue, 02/7/17 - 06:31 pm
Tags:
Gilead Sciences, earnings
3 Crucial Questions Gilead Sciences Should Answer Tuesday
Motley Fool
Sun, 02/5/17 - 12:47 pm
Tags:
Gilead Sciences, earnings
3 Critical Things to Watch in Gilead Sciences' Q4 Results
Motley Fool
Wed, 02/1/17 - 09:47 am
Tags:
Gilead Sciences, earnings
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
BioPharma Dive
Sat, 01/28/17 - 02:36 pm
Tags:
Merck, Sanofi, Eli Lilly, Pfizer, Roche, AstraZeneca, Gilead Sciences, Allergan, GSK
3 Companies Putting the Squeeze on Bristol-Myers Squibb
Motley Fool
Sat, 01/28/17 - 02:27 pm
Tags:
Bristol-Myers Squibb, Merck, Roche, Gilead Sciences
Forget Incyte: Gilead Sciences Would Be Better Off Buying This Company
Motley Fool
Wed, 01/25/17 - 09:53 am
Tags:
Gilead Sciences, Incyte, M&A, Galapagos
Has Gilead Sciences' Cash Cow Finally Hit Bottom?
Motley Fool
Mon, 01/23/17 - 10:26 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi, Harvoni
Gilead’s Vemlidy Hep B Drug Approved In EU
Investopedia
Sun, 01/15/17 - 11:16 am
Tags:
Gilead Sciences, hepatitis B, Vemlidy, Europe
Gilead Sciences: The M&A Question
Barron's
Fri, 01/13/17 - 09:34 am
Tags:
M&A, Gilead Sciences
Pharma industry needs to be more transparent on drug pricing, Gilead CEO says
CNBC
Wed, 01/11/17 - 10:03 am
Tags:
Pharma CEOs, drug pricing, Gilead Sciences, John Milligan, JPMHC 2017
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
Tags:
M&A, Gilead Sciences, JNJ, Pfizer, Merck, Novartis, Eli Lilly, Bristol-Myers Squibb, Biogen
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
Fri, 01/6/17 - 09:47 am
Tags:
biotech, Incyte, Biogen, Biomarin, Gilead Sciences, Illumina
Valeant Is A Strong Acquisition Target
Seeking Alpha
Thu, 01/5/17 - 09:36 am
Tags:
Valeant Pharmaceuticals, M&A, Gilead Sciences, Pfizer, Amgen
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
Tags:
biotech, M&A, drug launches, Gilead Sciences, Incyte, Spinraza, Biogen, Ionis Pharmaceuticals, Amgen, Regeneron, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.